Business Wire

Exclusive Group Acquires US VAD – Fine Tec

Del

Exclusive Group, the value-added services and technologies (VAST) group, today advanced its global distribution partner offering with the acquisition of leading Silicon Valley-headquartered cybersecurity VAD, Fine Tec. The move places Exclusive Group at the heart of the world’s largest cybersecurity market; complementing its existing global presence throughout the EMEA and APAC regions. Global systems integrators, service providers and vendors, as well as large North American reseller partners, will be the chief beneficiaries as Exclusive Group extends its unique, highly successful ‘Disruptive Distribution’ blueprint with an established local player that already shares similar DNA and value-adding culture.

“This will be a major step forward for our global proposition as we harness US-based skills, resources and relationships to support the execution of worldwide deals with large systems integrator partners and to advance our unique formula into the domestic market,” said Olivier Breittmayer, CEO of Exclusive Group. “Fine Tec is as an operationally excellent business with a strong services capability and successful reputation for delivering value in a highly competitive environment. It represents a great opportunity to integrate a culturally-aligned business into our global family, and we look forward to working with Fine Tec CEO James Shen and his team to build on their success and accelerate growth throughout the region.”

“This is great news for everyone connected with Fine Tec family as it validates the approach we’ve taken to value-added distribution in the US for nearly 20 years,” said James Shen, Fine Tec President & CEO. “The Exclusive Group story is well known and we’ve admired it from afar, but now with the Group’s global reach and resources it opens up many new opportunities for our partners. It really is an exciting time as there is true opportunity to extend the disruptive distribution model to the US, whilst the ambition for us to grow internationally is finally realised.”

Fine Tec is a $230m value-added distributor in network security, data integrity and storage solutions, with significant services and training capabilities. The move follows Exclusive Group’s recent appointment of Patrick Huth as VP Alliances Americas, who will be instrumental in enabling new partner and vendor opportunities alongside Fine Tec’s existing leadership team. The successful integration of the Fine Tec business is set to increase Exclusive Group’s forecast revenues for the full year 2017 to 1.8bn€ ($2bn).

-ends-

About Exclusive Group

Exclusive Group (www.exclusive-group.com) is the value-added services and technologies (VAST) group accelerating the growth of disruptive and innovative technologies around the world. Its people are committed to the high-growth imperatives of ambitious IT vendors and fueled by a strong culture of ambition, entrepreneurialism and sustainable growth.

With 50+ offices across five continents and presence in over 100 countries, Exclusive Group brings all the essential elements of a proven winning strategy for market entry and growth. Redefining value and enabling new market opportunities through “Disruptive Distribution” is at the heart of the Exclusive Group proposition through its cybersecurity brand, Exclusive Networks, and datacentre transformation division, BigTec. This is complemented by the extensive and innovative capabilities of PASSport Global Services, and the comprehensive, integrated commercial leasing offerings delivered by Exclusive Capital.

About Fine Tec

Starting as a value-added distributor (VAD) in the year 2000, Fine Tec has become the heart of an ecosystem comprised of leading and emerging technology vendors who provide network-security and data-integrity solutions for our broad network of resellers across North America. We’ve done this by maximizing sales opportunities for our partners while removing the hurdles that impede business transactions from before the sale to after the deployment.

Contact information

Cohesive
Greg Halse/Ellie Stansfield
+44 (0) 1291 626200
exclusivegroup@wearecohesive.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Shell, bio-bean and Coffee-Drinkers Collaborate to Help Power London’s Buses20.11.2017 00:01Pressemelding

Shell and bio-bean announce that together they are helping to power some of London’s buses using a biofuel made partly from waste coffee grounds. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005060/en/ Shell and bio-bean announce that together they are helping to power some of London's buses using a biofuel made partly from waste coffee grounds (Photo: Business Wire) The B20 biofuel contains a 20% bio-component which contains part coffee oil. The biofuel is being added to the London bus fuel supply chain and will help to power some of the buses; without need for modification. Biofuel provides a cleaner, more sustainable energy solution for buses across London’s network by decreasing emissions1. “Our Coffee Logs have already become the fuel of choice for households looking for a

Samsung Bioepis Receives Regulatory Approval for Europe's First Trastuzumab Biosimilar, ONTRUZANT®19.11.2017 22:21Pressemelding

Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) marketing authorization of ONTRUZANT ® , a biosimilar referencing Herceptin ® (trastuzumab), for the treatment of early breast cancer, metastatic breast cancer and metastatic gastric cancer. ONTRUZANT ® is the first trastuzumab biosimilar to receive regulatory approval in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005066/en/ Christopher Hansung Ko, President & CEO of Samsung Bioepis. (Photo: Business Wire) The EC approval of ONTRUZANT ® applies to all 28 European Union (EU) member states and the European Economic Area (EEA) member states of Norway, Iceland and Liechtenstein. ONTRUZANT ® will be commercial

Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life19.11.2017 16:31Pressemelding

Sharjah, the third largest of the United Arab Emirate’s seven emirates, was the host for the MENA region’s first ever ‘Global Relay for Life,’ (RFL) a 24-hour walkathon that is the biggest fundraising event for cancer in the world. Conducted in conjunction with the American Cancer Society, the event was organised by Friends of Cancer Patients (FoCP), a non-profit organisation that supports cancer patients and their families. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005048/en/ During MENA's first Global Relay For Life walkathon - Source: Friends of Cancer Patients Taking place November 17-18 at the American University Sharjah, the inaugural UAE RFL saw more than 2,000 relayers participating in the overnight event, with a large number of individuals and institutions involved including 52 sch

New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases18.11.2017 23:00Pressemelding

AstraZeneca today presented new data from a subgroup analysis of the Phase III FLAURA trial, which explored osimertinib as 1st-line therapy in patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Results presented at the ESMO Asia 2017 Congress in Singapore showed that patients with central nervous system (CNS) metastases at baseline had a higher objective response rate with their brain metastasis and suggest a lower risk of CNS progression when treated with osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), versus current standard-of-care EGFR-TKIs (erlotinib or gefitinib) [Abstract LBA5].1 The analysis included patients with ≥1 measurable and/or non-measurable CNS lesion present on baseline scan (as assessed by blinded independent central review), accounting for 23

New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer18.11.2017 18:20Pressemelding

AstraZeneca today announced that the New England Journal of Medicine has published the positive results from the Phase III FLAURA trial which provide data for Tagrisso’s (osimertinib) use in the 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).1 The trial showed a statistically significant, clinically meaningful progression-free survival (PFS) advantage for osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), compared with current 1st-line EGFR-TKIs, erlotinib or gefitinib.1 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171118005044/en/ Dr. Suresh S. Ramalingam, Principal Investigator of the FLAURA trial, from the Winship Cancer Institute

Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled18.11.2017 09:11Pressemelding

The 19th China Hi-Tech Fair (CHTF 2017), with the theme of “Innovation-Driven Development and Supply Quality Upgrade”, is taking place from November 16 to 21 at Shenzhen Convention and Exhibition Center. On the afternoon of November 10, the CHTF 2017 Top 10 Products were unveiled at the awards ceremony by Mr. Gao Zimin, Vice Mayor of Shenzhen City. A total of 322 entries competed for the honor Top 10 Products, and the voting lasted nearly 3 months. 60 candidate products in the fields of new energy, 3D print, flexible display, life sciences, unmanned vehicles and AI were shortlisted by the organizer, experts and media representatives and went for open voting online. The final Top 10 Products all represent the most advanced technologies in their respective sectors: the water-making device that can make water out of air, the smart sportswear that can monitor heartbeat and other

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom